Tricyclic compounds as anticancer agents
US9458156B2 · kind B2 · utility
22Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2014 |
| Grant date | Oct 4, 2016 |
| Priority date | — |
| Expiry date | Dec 23, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.